NCT04586088 2023-05-06
Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
18 trialsNCT03048877 2023-04-12
Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT05549466 2023-02-08
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
Sun Yat-sen University
Phase 2 Unknown
NCT04440917 2021-02-02
IMplus
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT04612894 2020-11-03
Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
Fudan University
Phase 2 Unknown
NCT04547088 2020-09-14
Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT04548271 2020-09-14
Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT04180007 2019-11-27
APT-01
Nanjing First Hospital, Nanjing Medical University
Phase 2 Unknown
NCT03654612 2018-10-18
Y-HR2017-025
China International Medical Foundation
Phase 1/2 Unknown
NCT03096184 2018-10-09
A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT03612219 2018-08-02
Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma
Guilin Medical University, China
Phase 2 Unknown
NCT03539172 2018-05-30
RASS
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT03130270 2018-05-16
Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma
Guilin Medical University, China
Phase 2 Unknown
NCT03424291 2018-02-06
A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03300765 2017-10-03
Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
Fudan University
Phase 2 Unknown
NCT03213587 2017-07-11
Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02989259 2016-12-13
Apatinib for Advanced Non-squamous Head and Neck Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT02943252 2016-10-24
The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown